![](/img/cover-not-exists.png)
A phase 1 study of IPI-504 (retaspimycin hydrochloride) in patients with relapsed or relapsed and refractory multiple myeloma
Siegel, David, Jagannath, Sundar, Vesole, David H., Borello, Ivan, Mazumder, Amitabha, Mitsiades, Constantine, Goddard, Jill, Dunbar, Joi, Normant, Emmanuel, Adams, Julian, Grayzel, David, Anderson, KVolume:
52
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2011.600481
Date:
December, 2011
File:
PDF, 280 KB
english, 2011